Financhill
Back

Asensus Surgical Quote, Financials, Valuation and Earnings

Asensus Surgical Price Quote

$0.34
+0.00 (+0.56%)
(Updated: July 17, 2024 at 5:29 AM ET)

Asensus Surgical Key Stats

Sell
44
Asensus Surgical (ASXC) is a Sell

Day range:
$0.34 - $0.34
52-week range:
$0.20 - $0.63
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
10.00
P/B ratio:
7.1%

Volume:
843.1K
Avg. volume:
3.7M
1-year change:
-39.77%
Market cap:
$92.4M
Revenue:
$8.6M
EPS:
$-0.3

How Much Does Asensus Surgical Make?

Is Asensus Surgical Growing As A Company?

  • What Is Asensus Surgical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.15%
  • What Is Asensus Surgical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Asensus Surgical Stock Price Performance

  • Did Asensus Surgical Stock Go Up Last Month?
    Asensus Surgical share price went up by 2.76% last month
  • Did ASXC's Share Price Rise Over The Last Year?
    ASXC share price fell by -39.77% over the past 1 year

What Is Asensus Surgical 52-Week High & Low?

Asensus Surgical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Asensus Surgical?

  • How Much Debt Does Asensus Surgical Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Asensus Surgical Have?
    Cash and short term investments quarterly total is $8M
  • What Is Asensus Surgical’s Book Value Per Share?
    Book value per share is 0.05

Is Asensus Surgical Cash Flow Positive?

  • What Is ASXC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$60.4M
  • What Is Asensus Surgical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.9M
  • What Is Asensus Surgical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $37.8M

Asensus Surgical Return On Invested Capital

  • Is Management Doing A Good Job?
    ASXC return on invested capital is -167.54%
  • What Is Asensus Surgical Return On Assets?
    ROA measures how assets are converting to revenues and is -113.9%
  • What Is ASXC Return On Equity?
    ROE is a measure of profitability and is -167.54%

Asensus Surgical Earnings Date & Stock Price

Asensus Surgical Competitors

  • Who Are Asensus Surgical's Competitors?
    Below is a list of companies who compete with Asensus Surgical or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Asensus Surgical Dividend Yield

Data Unavailable

Asensus Surgical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -40%
Revenue: 15.06% -6.22%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 0.35
Upside from Last Price: 3.21%

Major Shareholders

  • How many ASXC shares are owned by institutional investors?
    39.3M ASXC shares are owned by institutional investors
  • How many ASXC shares are owned by insiders?
    9.6M ASXC shares are owned by insiders